Effectiveness of smoking cessation interventions: Review of evidence and implications for best practice in Australian health care settings

Australian and New Zealand Journal of Public Health

Volumn 27, Issue 3, 2003, Pages 300-309

  Miller, Margaret ^a   Wood, Lisa ^b  

^a Marg Miller Health Consulting   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETATE SILVER; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLONIDINE; DRUGS USED IN THE TREATMENT OF ADDICTION; FLUOXETINE; MECAMYLAMINE; NALTREXONE; NICOTINE DERIVATIVE; NORTRIPTYLINE; UNCLASSIFIED DRUG;

ACUPUNCTURE; AUSTRALIA; BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG CONTRAINDICATION; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; HYPNOSIS; LONG TERM CARE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MOTIVATION; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PATIENT COUNSELING; REVIEW; SELF HELP; SHORT COURSE THERAPY; SIDE EFFECT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH;

EID: 0037702866     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2003.tb00399.x     Document Type: Review

References (85)

1. Australian Institute of Health and Welfare. Australia's Health 2000. Canberra: AIHW; 2000. AIHW Catalogue No.: 19.
2. Borland R, Hill D. Two month follow up on callers to a telephone quit smoking service. Drug Alcohol Rev 1990;9:211-8.
3. US Centers for Disease Control. Cigarette smoking among adults - United States. MMWR Morb Mortal Wkly Rep 1997;46:1217-20.
4. Tobacco, Alcohol and Illicit Drug Survey. Perth: Health Department of Western Australia; 1997.
5. Fiore M, Bailey W, Cohen S, Dorfman S, et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Maryland: US Department of Health and Human Services; 2000.
6. Shiffman S, Gitchell J. World's best practice in tobacco control: Increasing quitting by increasing access to treatment medications: USA. Tob Control 2000;9:230.
7. Carmody T. Preventing relapse in the treatment of nicotine addiction: Current issues and future directions. J Psychoactive Drugs 1992;24(2):131-58.
8. Reducing Tobacco Use [report of the Surgeon General]. Georgia: US Department of Health and Human Services; 2000.
9. Zhu S, Melcer T, Sun J, Rosbrook B, et al. Smoking cessation with and without assistance. A population-based analysis. Am J Prev Med 2000;18(4):305-11.
10. Hughes J. Smoking cessation. N Engl J Med 1999;341(8):610-1.
11. Dickinson J, Wigers J, Leeder S, Sanson-Fisher R. General practitioners' detection of patients' smoking status. Med J Aust 1989;150:420-6.
12. Feeney GF, Kelly A, Griffin DK, Young RM. Smoking interventions within the hospital setting: A study of demand for smoking interventions and perceived efficacy of nurses in delivery of services. Health Prom J Aust 1997;7(1):52-6.
13. Young J, Ward J. Improving smoking cessation advice in Australian general practice: What do GPs suggest is needed? Aust N Z J Public Health 1998;22(7):777-80.
14. Young J, Ward J. Implementing guidelines for smoking cessation advice in Australian general practice: Opinions, current practices, readiness to change and perceived barriers. Fam Prac 2001;18:14-20.
15. Mattick R, Baillie A. An Outline for Approaches to Smoking Cessation: Quality Assurance Project. Canberra: AGPS; 1992.
16. Miller M, Wood L. Smoking cessation interventions: Review of evidence and implications for best practice in health care setting. National Tobacco Strategy 1999-2002/03 [occasional paper]. Canberra: Commonwealth Department of Health and Ageing; 2001.
17. Fiore M, Bailey W, Cohen S, Dorfman S, et al. Smoking Cessation Clinical Practice Guideline No 18. Georgia: Agency for Health Care Policy and Research, US Department of Health and Human Services; 1996.
18. National Advisory Committee on Health and Disability. Guidelines for Smoking Cessation: Literature Review and Background Information. Wellington: New Zealand Ministry of Health; 1999.
19. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: An update. Thorax 2000;55(12):987-99.
20. Action on Smoking and Health Scotland. Smoking cessation guidelines for Scotland. Edinburgh: Health Education Board for Scotland; 2000. Available from: http://www.hebs.scot.nhs.uk [cited 2002 May 30].
21. National Health and Medical Research Council. How to Assess the Evidence: Assessment and Application of Scientific Evidence. Canberra: NHMRC; 2000.
22. Abbot N, Stead L, White A, Barnes J. Hypnotherapy for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
23. Gourlay S, Stead L, Benowitz N. Clonidine for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
24. Hajek P, Stead L. Aversive smoking for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
25. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
26. Hughes J, Stead L, Lancaster T. Anxiolytics for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
27. Lancaster T, Stead L. Silver acetate for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
28. Lancaster T, Stead L. Mecamylamine for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
29. Lancaster T, Stead L. Individual behavioural counselling for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
30. Lancaster T, Stead L. Self-help interventions for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
31. Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
32. Rigotti N, Munafo M, Murphy M, Stead L. Interventions for smoking cessation in hospitalized patients (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
33. Silagy C, Stead L. Physician advice for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
34. White A, Rampes H, Ernst E. Acupuncture for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
35. Rice V, Stead L. Nursing interventions for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
36. Silagy C, Lancaster T, Stead L, Mant D, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
37. Stead L, Hughes J. Lobeline for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
38. Ussher M, West R, Taylor A, McEwen A. Exercise interventions for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
39. Stead L, Lancaster T. Group behaviour therapy programmes for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
40. Stead L, Lancaster T. Telephone counseling for smoking cessation (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 1, 2002. Oxford: Update Software; 2002.
41. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library. Br Med J 2000;321(7257):355-8.
42. Windsor R, Boyd N, Orleans C. A meta-evaluation of smoking cessation intervention research among pregnant women: Improving the science and art. Health Educ Res 1998;13(3):419-38
43. Melvin C, Dolan-Mullen P, Windsor R, Pennington W, et al. Recommended cessation counselling for pregnant women who smoke; A review of the evidence. Tob Control 2000;9 Suppl 3:80-4.
44. Owen N, Roberts L, Wakerfield M. The South Australian Quit Advisory Service: Characteristics of callers and cessation outcomes. Health Prom J Aust 1995;5(3):49-50.
45. Platt S, Tannahill A, Watson J, Fraser E. Effectiveness of anti-smoking telephone helpline: Follow up survey. Br Med J 1997;314:1371-5.
46. Wakefield M, Miller C. Evaluaton of the national quitline service. In: Hassard K, editor. Australia's National Tobacco Campaign, Evaluation Report, Vol. 1. Canberra: Commonwealth Department of Health and Aged Care; 1999.
47. Owen L. Impact of a telephone helpline for smokers who called during a mass media campaign. Tob Control 2000;9:148-54.
48. Prochaska J, Di Clemente C, Velicer W, Rossi J. Standardised, individualised, interactive and personalised self-help programs for smoking cessation. Health Psychol 1993;12(5):339-405.
49. Rimer B, Orleans C, Fleisher L, Crishnzio S. Does tailoring matter? The impact of a tailored guide on ratings and short-term smoking related outcomes for older smokers. Health Educ Res 1994;9:69-84.
50. Borland R, Segan C, Livingston P, Owen N. The effectiveness of callback counselling for smoking cessation: A randomised trial. Addiction 2001;96(6):881-9.
51. Hardin PC, Reis J. Interactive multimedia software design: Concepts, process and evaluation. Health Educ Behav 1997;24(1):35-53.
52. Dijkstra A, De Vries H, Roijackers J. Targeting smokers with low readiness to change with tailored and nontailored self-help materials. Prev Med 1999;28(2):203-11.
53. Carroll K. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Exp Clin Psychopharmacol 1996;4(1):46-54.
54. Wood G, Cecchini J, Nathason N, Hiroshige K. Office-based training in tobacco cessation for dental professionals. J Am Dent Assoc 1997;28(2):216-24.
55. Clover K, Hazell T, Stanbridge V, Sanson-Fisher R. Dentists' attitudes and practice regarding smoking. Aust Dent J 1999;44(1):46-50.
56. Sinclair H, Bond C, Lennox A, Silcock J, et al. Training pharmacists and pharmacy assistants in the stages-of-change model of smoking cessation: A randomised controlled trial in Scotland. Tob Control 1998;7(3):253-61.
57. McElnay JC, Maguire TA, Drummond A, Hughes CM. Smoking cessation: The contribution of community pharmacy. Dis Man Health Outcomes 2000;8(3):147-58.
58. Carroll P, Fois R, Sarson D, Flynn J. A community pharmacy-based smoking cessation program using transdermal nicotine replacement therapy - Actions and outcomes. Aust Pharm 2000;19(1):51-5.
59. Dunkley J. Training midwives to help pregnant women to stop smoking. Nurs Times 1997;93:64-6.
60. Secker-Walker R, Solomon L, Flynn B, Lepage S, et al. Training obstetric and family practice residents to give smoking cessation advice during prenatal care. Am J Obstet Gynecol 1992;166:1356-63.
61. Klein J. Incorporating effective smoking prevention and cessation counselling into practice. Pediatr Ann 1995;24(12):646-52.
62. Wall M, Severson M, Andrews J, Lichenstein E, et al. Pediatric office-based smoking intervention: Impact on maternal smoking and relapse. Pediatrics 1995;96(4):622-8.
63. Irvine L, Crombie I, Clark R, Slane P, et al. Advising parents of asthmatic children on passive smoking: Randomised control trial. Br Med J 1999;318(7196):1456-9.
64. Ahluwalia J, Gibson C, Kenney R, Wallace D, et al. Smoking status as a vital sign. J Gen Intern Med 1999;14(7):402-8.
65. Dickey L, Gemson D, Carney P. Office system interventions supporting primary care-based health behavior change counseling. Am J Prev Med 1999;17(4):299-308.
66. Lichtenstein E, Glasgow R, Lando H, Ossip-Klein D, et al. Telephone counselling for smoking cessation: Rationales and meta-analytic review of evidence. Health Educ Res 1996;11(2):243-57.
67. Miller N, Smith P, Debusk R, Sobel D, et al. Smoking in hospitalised patients - Results of a randomised trial. Arch Intern Med 1997;157:409-15.
68. Zhu S, Tedeschi G, Anderson C, Rosbrook B, et al. Telephone counseling as adjuvant treatment for nicotine replacement therapy in a 'real world' setting. Prev Med 2000;31(4):357-63.
69. Bohadana A, Nilsson F, Raasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomised, double-blind, placebo-controlled trial. Arch Intern Med 2000;160(20):3128-34.
70. Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, et al. Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow up. Br Med J 1999;318(7179):285-8.
71. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999;67(4):547-54.
72. Tashkin D, Kanner R, Bailey W, Buist S, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial. Lancet 2001;357(9268):1571-5.
73. Gonzales D, Nides M, Ferry L, Kustra R, et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomised placebo-controlled study. Clin Pharmacol Ther 2001;69(6):438-44.
74. Dale L, Glover E, Sachs D, Schroeder D, et al. Bupropion for smoking cessation: Predictors of successful outcome. Chest 2001;119(5):1357-64.
75. Hertzberg M, Moore S, Feldman M, Beckham J. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol 2001;21(1):94-8.
76. Jorenby DE, Leischow SJ, Nides MA, Renmard SI, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340(9):685-91.
77. Blondal T, Gudmundsson LJ, Tomasson K, Jonsdottir D, et al. The effects of fluoxetine combined with nicotine inhalers in smoking cessation - A randomized trial. Addiction 1999;94(7):1007-15.
78. Niaura R, Spring B, Borrelli B, Hedeker D, et al. Multicentre trial of fluoxetine as adjunct to behavioural smoking cessation treatment. J Consult Clin Psychol 2002;70(4):887-96.
79. Green JP, Lynn SJ. Hypnosis and suggestion-based approaches to smoking cessation: An examination of the evidence. Int J Clin Exp Hypn 2000;48(2):195-224.
80. Hurt R, Sachs D, Glover E, Offord K, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337(17):1195-202.
81. Hall SM, Reus VI, Munoz RF, Sees KL, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998;55(8):683-90.
82. Hayford K, Patten C, Rummans T, Schroeder D, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999;174(9):173-8.
83. Joseph A, Antonnucio D. Lack of efficacy of transdermal nicotine in smoking cessation. N Engl J Med 1999;341(8):610-1.
84. Wiggers J, Sanson-Fisher R. Practitioner provision of preventive care in general practice consultations: Association with patient educational and occupational status. Soc Sci Med 1997;44:137-46.
85. Ossip-Klein D, Giovino G, Megahed N, Black P, et al. Effects of a smoker's hotline: Results of a 10 county self help trial. J Consul Clin Psychol 1991;59:325-32.